Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.3K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.3K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.7K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

7.6K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
7.6K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NOTO: Noise-Tolerate Evidential Learning for Open-Set Cross-Modal Retrieval.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

Frailty status and the risk of dementia, Alzheimer's disease: a meta-analysis of observational studies.

Frontiers in neurology·2026
Same author

Comparative efficacy of executive function interventions for Chinese children with neurodevelopmental disorders: A network meta-analysis.

Frontiers in psychology·2026
Same author

Deep Information-Balanced Multimodal Learning.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

Social isolation, loneliness and the risk of Frailty status: a meta-analysis of observational studies.

Archives of gerontology and geriatrics·2026
Same author

Mussel-Inspired Adhesive Layer Supporting ZnO Nanorod Arrays Combined with Thiol-Ene Click Reaction for Constructing Multi-Level Carbon Fiber/Norbornene-Polyimide Interfaces.

Materials (Basel, Switzerland)·2026

Related Experiment Video

Updated: Sep 2, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

Multi-scaled self-attention for drug-target interaction prediction based on multi-granularity representation.

Yuni Zeng1, Xiangru Chen2, Dezhong Peng2,3,4

  • 1School of Information Science and Technology, Zhejiang Sci-Tech University, Hangzhou, China.

BMC Bioinformatics
|August 3, 2022
PubMed
Summary

This study introduces a novel deep learning model for drug-target interaction (DTI) prediction. The new method enhances chemical textual information encoding and pattern extraction, improving prediction accuracy for drug discovery.

Keywords:
Deep learningDrug–target interactionRepresentations learningSelf-attention networks

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K

Related Experiment Videos

Last Updated: Sep 2, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K

Area of Science:

  • Bioinformatics
  • Computational Chemistry
  • Drug Discovery

Background:

  • Drug-target interaction (DTI) prediction is vital for drug discovery.
  • Current deep learning methods for DTI prediction have limitations in encoding chemical information and capturing complex patterns.
  • Existing character encoding methods overlook crucial chemical details in drug and protein sequences.

Purpose of the Study:

  • To propose a novel deep learning model for improved DTI prediction.
  • To address limitations in existing encoding methods and deep model architectures for DTI prediction.

Main Methods:

  • Developed a multi-granularity encoding method using sequence segmentation for drugs and proteins.
  • Implemented a multi-scaled self-attention network (SAN) to extract diverse local patterns from multi-granularity representations.
  • Fused deep representations of drugs and targets for final DTI prediction.

Main Results:

  • The proposed model demonstrated superior prediction accuracy compared to strong baseline models on KIBA and Davis datasets.
  • The multi-granularity encoding effectively captures chemical textual information.
  • The multi-scaled SAN successfully extracts various local patterns in drug and target representations.

Conclusions:

  • The novel multi-granularity encoding and multi-scaled SAN model significantly enhance DTI prediction.
  • The approach improves the encoding of chemical textual information and extraction of local patterns.
  • This work offers a promising advancement for computational drug discovery and development.